| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4581435
Max Phase: Preclinical
Molecular Formula: C22H20N4O3
Molecular Weight: 388.43
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccccc1Cc1cc(C)nn(CC(=O)Nc2ccc(C#N)cc2)c1=O
Standard InChI: InChI=1S/C22H20N4O3/c1-15-11-18(12-17-5-3-4-6-20(17)29-2)22(28)26(25-15)14-21(27)24-19-9-7-16(13-23)8-10-19/h3-11H,12,14H2,1-2H3,(H,24,27)
Standard InChI Key: LOGQKDBAHABNGM-UHFFFAOYSA-N
Associated Targets(Human)
Formyl peptide receptor 1 1372 Activities
Lipoxin A4 receptor 3472 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 388.43 | Molecular Weight (Monoisotopic): 388.1535 | AlogP: 2.66 | #Rotatable Bonds: 6 |
| Polar Surface Area: 97.01 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.68 | CX Basic pKa: | CX LogP: 2.51 | CX LogD: 2.51 |
| Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.70 | Np Likeness Score: -1.83 |
References
| 1. Deora GS, Qin CX, Vecchio EA, Debono AJ, Priebbenow DL, Brady RM, Beveridge J, Teguh SC, Deo M, May LT, Krippner G, Ritchie RH, Baell JB.. (2019) Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists., 62 (10): [PMID:31038950] [10.1021/acs.jmedchem.8b01912] |
Source
Source(1):